UK

Corrigendum

Information

Published

External Reference: 2024-515303

FTS Reference: 2024-016433

Corrigendum

Corrigendum

Notice for changes or additional information

Supplies

Section I: Contracting authority/entity

I.1)

Name and addresses

Nottingham Trent University (NTU)
GB 277399933
50 Shakespeare Street
Nottingham
NG1 4FQ
UK
Contact person: Mark Lucas
Telephone: +44 1158488747
E-mail: mark.lucas@ntu.ac.uk
NUTS code:  UKF14 -  Nottingham
Internet address(es):
Main address: https://www.ntu.ac.uk/
Address of the buyer profile: https://uk.eu-supply.com/ctm/Company/CompanyInformation/Index/128806

Section II: Object

II.1)

Scope of the procurement

II.1.1)

Title

Clinical Trial Manufacturing and Distribution Services
Reference number:  NTU/24/2615/ML
II.1.2)

Main CPV code

33600000  -  Pharmaceutical products
II.1.3)

Type of contract

Supplies
II.1.4)

Short description

Nottingham Trent University is conducting preliminary market research to understand the capabilities and services available in the pharmaceutical sector that can support an upcoming clinical trial. This pre-market engagement aims to gather information from qualified suppliers in two distinct areas: manufacturing and distribution of fluoxetine (20mg) and a matching placebo. Responses to this request will inform our procurement strategy and may lead to a formal invitation to tender.

Section VI: Complementary information

VI.6)

Original notice reference

Notice number in the FTS: 2024/S 000-014973

Section VII: Changes

VII.1)

Information to be changed or added

VII.1.2)

Text to be corrected in the original notice

VII.2)

Other additional information

Extension of deadline from 10AM, 29/05/2024 to 10AM 07/06/2024 facilitate submission of pre-market engagement responses.